XML 56 R11.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Financial Instruments And Derivatives
6 Months Ended
Jul. 03, 2011
Financial Instruments And Derivatives  
Financial Instruments And Derivatives

E. Financial Instruments and Derivatives

Financial Instruments

Teradyne uses the market and income approach to value its financial instruments and there was no change in valuation techniques used by Teradyne during the six months ended July 3, 2011 and July 4, 2010. As defined in ASC 820-10, "Fair Value Measurements and Disclosures", fair value is the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants. ASC 820-10 requires that assets and liabilities are carried at fair value and are classified in one of the following three categories:

Level 1: Quoted prices in active markets for identical assets as of the reporting date.

Level 2: Inputs other than Level 1, that are observable either directly or indirectly as of the reporting date. For example, a common approach for valuing fixed income securities is the use of matrix pricing. Matrix pricing is a mathematical technique used to value securities by relying on the securities' relationship to other benchmark quoted prices.

Level 3: Unobservable inputs that are not supported by market data. Unobservable inputs are developed based on the best information available, which might include Teradyne's own data.

For the right to sell the auction rate securities, held by Teradyne, back to UBS ("UBS Put"), Teradyne elected fair value treatment under ASC 825-10, "Financial Instruments." The UBS Put was the only instrument of this nature or type that Teradyne held and for which Teradyne has elected the fair value option under ASC 825-10. The UBS Put was exercised in June 2010.

During the six months ended July 3, 2011 and July 4, 2010, there were no significant transfers in and out of Level 1 and Level 2.

The following table sets forth by fair value hierarchy Teradyne's financial assets and liabilities that were measured at fair value on a recurring basis as of July 3, 2011 and December 31, 2010.

 

    July 3, 2011  
    Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)
    Significant
Other
Observable
Inputs
(Level 2)
    Significant
Unobservable
Inputs
(Level 3)
    Total  
    (in thousands)  

Assets

       

Available for sale securities:

       

Money market funds

  $ 288,944      $ —        $ —        $ 288,944   

U.S. government agency securities

    —          240,102        —          240,102   

Commercial paper

    —          235,540        —          235,540   

U.S. Treasury securities

    138,455        —          —          138,455   

Corporate debt securities

    —          129,084        —          129,084   

Equity and debt mutual funds

    8,754        —          —          8,754   

Certificates of deposit and time deposits

    —          8,381        —          8,381   

Non-U.S. government securities

    298        —          —          298   
 

 

 

   

 

 

   

 

 

   

 

 

 

Total

    436,451        613,107        —          1,049,558   

Derivatives

    —          135        —          135   
 

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 436,451      $ 613,242      $ —        $ 1,049,693   
 

 

 

   

 

 

   

 

 

   

 

 

 

Reported as follows:

 

     (Level 1)      (Level 2)      (Level 3)      Total  
     (in thousands)  

Assets

           

Cash and cash equivalents

   $ 288,944       $ 24,694       $ —         $ 313,638   

Marketable securities

     64,529         389,413         —           453,942   

Long-term marketable securities

     82,978         199,000         —           281,978   

Prepayments and other current assets

     —           135        —           135   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 436,451       $ 613,242       $ —         $ 1,049,693   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

    December 31, 2010  
    Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)
    Significant
Other
Observable
Inputs
(Level 2)
    Significant
Unobservable
Inputs
(Level 3)
    Total  
    (in thousands)  

Assets

       

Available for sale securities:

       

U.S. government agency securities

  $ —        $ 341,510      $ —        $ 341,510   

Money market funds

    238,607        —          —          238,607   

U.S. Treasury securities

    138,707        —          —          138,707   

Commercial paper

    —          103,448        —          103,448   

Corporate debt securities

    —          92,578        —          92,578   

Certificates of deposit and time deposits

    —          11,076        —          11,076   

Equity and debt mutual funds

    8,003        —          —          8,003   

Non-U.S. government securities

    278        —          —          278   
 

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 385,595      $ 548,612      $ —        $ 934,207   
 

 

 

   

 

 

   

 

 

   

 

 

 

Liabilities

       

Derivatives

  $ —        $ 157      $ —        $ 157   
 

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ —        $ 157      $ —        $ 157   
 

 

 

   

 

 

   

 

 

   

 

 

 

Reported as follows:

 

     (Level 1)      (Level 2)      (Level 3)      Total  
     (in thousands)  

Assets

           

Cash and cash equivalents

   $ 238,607       $ 37,843       $ —         $ 276,450   

Marketable securities

     62,294         346,767         —           409,061   

Long-term marketable securities

     84,694         164,002         —           248,696   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 385,595       $ 548,612       $ —         $ 934,207   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Other accrued liabilities

   $ —         $ 157       $ —         $ 157   
  

 

 

    

 

 

    

 

 

    

 

 

 

The following table represents changes in the fair value of Level 3 financial assets:

 

    For the Three Months Ended  
    July 3, 2011     July 4, 2010  
    Long-Term
Auction Rate
Securities
    UBS Put     Long-Term
Auction Rate
Securities
    UBS Put  
    (in thousands)  

Balance at beginning of period

  $ —        $ —        $ 23,697      $ 2,687   

Sale of auction rate securities and exercise of UBS Put

    —          —          (20,863     (2,687

Change in unrealized gain included in interest income

    —          —          2        —     
 

 

 

   

 

 

   

 

 

   

 

 

 

Balance at end of period

  $ —        $ —        $ 2,836      $ —     
 

 

 

   

 

 

   

 

 

   

 

 

 
    For the Six Months Ended  
    July 3, 2011     July 4, 2010  
    Long-Term
Auction Rate
Securities
    UBS Put     Long-Term
Auction Rate
Securities
    UBS Put  
    (in thousands)  

Balance at beginning of period

  $ —        $ —        $ 23,649      $ 2,830   

Sale of auction rate securities and exercise of UBS Put

    —          —          (21,013     (2,687 )

Change in unrealized gain included in interest income

    —          —          200        —     

Change in unrealized loss included in interest expense and other

    —          —          —          (143
 

 

 

   

 

 

   

 

 

   

 

 

 

Balance at end of period

  $ —        $ —        $ 2,836      $ —     
 

 

 

   

 

 

   

 

 

   

 

 

 

During the three and six months ended July 3, 2011, Teradyne recorded a net gain of $0.1 million and a net loss $0.1 million, respectively, from sales of marketable securities. During the three and six months ended July 4, 2010, Teradyne recorded a loss of $0.1 million and $0.4 million, respectively, from sales of marketable securities and exercise of UBS Put.

Realized losses from sales of marketable securities, decreases in auction rate securities fair value and other-than-temporary impairment losses are included in interest expense and other. Realized gains from sales of marketable securities and increases in auction rate securities fair value are included in interest income.

The carrying amounts and fair values of financial instruments at July 3, 2011 and December 31, 2010 were as follows:

 

The fair values of cash, accounts receivable, net and accounts payable approximate the carrying amount due to the short term maturities of these instruments.

The following table summarizes available-for-sale marketable securities which are recorded at fair value:

 

    July 3, 2011  
    Available-for-Sale     Fair Market
Value of Investments
with Unrealized  Losses
 
    Cost     Unrealized
Gain
    Unrealized
(Loss)
    Fair Market
Value
   
    (in thousands)  

Money market funds

  $ 288,944      $ —        $ —        $ 288,944      $ —     

U.S. government agency securities

    239,366        764        (28     240,102        30,074   

Commercial paper

    235,556        17        (33     235,540        48,880   

U.S. Treasury securities

    137,934        533        (12     138,455        28,665   

Corporate debt securities

    128,664        497        (77     129,084        37,248   

Equity and debt mutual funds

    7,518        1,236        —          8,754        —     

Certificates of deposit and time deposits

    8,365        16        —          8,381        —     

Non-U.S. government securities

    298        —          —          298        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $ 1,046,645      $ 3,063      $ (150   $ 1,049,558      $ 144,867   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

Reported as follows:

 

    Cost     Unrealized
Gain
    Unrealized
(Loss)
    Fair Market
Value
    Fair Market
Value of Investments
with Unrealized Losses
 
    (in thousands)  

Cash and cash equivalents

  $ 313,639      $ —        $ (1   $ 313,638      $ 10,946   

Marketable securities

    453,619        367        (44     453,942        61,468   

Long-term marketable securities

    279,387        2,696        (105     281,978        72,453   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $ 1,046,645      $ 3,063      $ (150   $ 1,049,558      $ 144,867   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

    December 31, 2010  
    Available-for-Sale     Fair Market
Value of Investments
with Unrealized  Losses
 
    Cost     Unrealized
Gain
    Unrealized
(Loss)
    Fair Market
Value
   
    (in thousands)  

U.S. government agency securities

  $ 341,349      $ 334      $ (173   $ 341,510      $ 97,542   

Money market funds

    238,607        —          —          238,607        —     

U.S. Treasury securities

    138,354        360        (7     138,707        10,030   

Commercial paper

    103,472        1        (25     103,448        33,210   

Corporate debt securities

    92,464        170        (56     92,578        43,434   

Certificates of deposit and time deposits

    11,068        8        —          11,076        —     

Equity and debt mutual funds

    7,056        1,378        (431     8,003        1,088   

Non-U.S. government securities

    261        17        —          278        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  $ 932,631      $ 2,268      $ (692   $ 934,207      $ 185,304   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Reported as follows:

 

     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair Market
Value
     Fair Market
Value of Investments
with Unrealized Losses
 
     (in thousands)  

Cash and cash equivalents

   $ 276,447       $ 3       $ —        $ 276,450       $ —     

Marketable securities

     408,934         178         (51     409,061         103,761   

Long-term marketable securities

     247,250         2,087         (641     248,696         81,543   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 932,631       $ 2,268       $ (692   $ 934,207       $ 185,304   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

On a quarterly basis, Teradyne reviews its investments to identify and evaluate those that have an indication of a potential other-than-temporary impairment. Factors considered in determining whether a loss is other-than-temporary include:

 

   

The length of time and the extent to which the market value has been less than cost;

 

   

The financial condition and near-term prospects of the issuer; and

 

   

The intent and ability to retain the investment in the issuer for a period of time sufficient to allow for any anticipated recovery in market value.

As of July 3, 2011, the fair market value of investments with unrealized losses less than one year totaled $144.9 million. There were no unrealized losses greater than one year. As of December 31, 2010, the fair market value of investments with unrealized losses totaled $185.3 million. Of this value, $5.0 million had unrealized losses greater than one year and $180.3 million had unrealized losses less than one year.

 

Derivatives

Teradyne conducts business in a number of foreign countries, with certain transactions denominated in local currencies. The purpose of Teradyne's foreign currency management is to minimize the effect of exchange rate fluctuations on certain foreign denominated net monetary assets. Teradyne does not use derivative financial instruments for trading or speculative purposes.

To minimize the effect of exchange rate fluctuations associated with the remeasurement of net monetary assets and liabilities denominated in foreign currencies, Teradyne enters into foreign currency forward contracts. The change in fair value of these derivatives is recorded directly in earnings, and is used to offset the change in fair value of the net monetary assets and liabilities denominated in foreign currencies.

The notional amount of foreign exchange contracts hedging monetary assets and liabilities denominated in foreign currencies was $49.5 million and $48.3 million at July 3, 2011 and December 31, 2010, respectively.

The following table summarizes the fair value of derivative instruments at July 3, 2011 and December 31, 2010.

 

    

Balance Sheet Location

  July 3,
2011
    December 31,
2010
 
         (in thousands)  

Derivatives not designated as hedging instruments:

      

Foreign exchange contracts

  

Prepayments and other current assets

  $ 135      $ —     

Foreign exchange contracts

  

Other accrued liabilities

    —          157   
    

 

 

   

 

 

 
     $ 135     $ 157   
    

 

 

   

 

 

 

The following table summarizes the effect of derivative instruments in the statement of operations recognized during the three and six months ended July 3, 2011 and July 4, 2010. The table does not reflect the corresponding gains (losses) from the remeasurement of the monetary assets and liabilities denominated in foreign currencies.

 

   

Location of Gains (Losses)
Recognized in Statement
of Operations

  For the Three Months
Ended
    For the Six Months
Ended
 
    July 3,
2011
    July 4,
2010
    July 3,
2011
    July 4,
2010
 
        (in thousands)  

Derivatives not designated as hedging instruments:

         

Foreign exchange contracts

 

Interest expense and other

  $ (166   $ (574   $ 660      $ (1,260
   

 

 

   

 

 

   

 

 

   

 

 

 
    $ (166   $ (574   $ 660      $ (1,260
   

 

 

   

 

 

   

 

 

   

 

 

 

See Note F "Debt" regarding derivatives related to convertible senior notes.